Frontiers in Hematology

Case Report

Accepted on 30 Jun 2025

Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: A case report

in Immunobiology and Immunotherapy

Nannan Lu
Yajing Zhang
Chunmeng Wang
Qingming Yang
Guanghua Rong
Yang Liu
Weidong Han

Frontiers in Hematology

doi 10.3389/frhem.2025.1616504

Case Report

Accepted on 26 Jun 2025

Co-occurrence of AIDS and Acute Promyelocytic Leukemia: A Case Report and Review of the Literature

in Blood Cancer

Shiwei Duan
Cheng Ai
Jianqiao Shentu
Hening Xu
Yongming Xia

Frontiers in Hematology

doi 10.3389/frhem.2025.1527938

Brief Research Report

Accepted on 23 Jun 2025

The "added value" of enrolling hematological patients in clinical trials: a single-centre experience. Author information: Stefano Loiacono 1 (0000-0001-9136-1351), Elisa Lucchini 2 (0000-0002-4857-8325)

in Blood Cancer

Stefano Loiacono
Elisa Lucchini
Maria Chiara Rossetti
Clara Palmieri
Irina Cebulec
Riccardo Provasi
Martina Lena
Eleonora De Bellis
Chiara Roni
Francesco Zaja

Frontiers in Hematology

doi 10.3389/frhem.2025.1613099

Review

Accepted on 23 Jun 2025

The Therapeutic Perspective of Relapsed/Refractory Waldenström Macroglobulinemia: What Comes Next?

in Blood Cancer

Nicolò Danesin
Giovanni Leone
Mattia D'antiga
Marco Carraro
Greta Scapinello
LIVIO TRENTIN
Francesco Piazza

Frontiers in Hematology

doi 10.3389/frhem.2025.1624046

102 views

Review

Published on 23 Jun 2025

Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting

in Immunobiology and Immunotherapy

Samuel Davis
Forat Lutfi

Frontiers in Hematology

doi 10.3389/frhem.2025.1610794

388 views

Case Report

Published on 23 Jun 2025

Case report: Clinical characteristics and genetic analysis of a familial platelet disorder associated with RUNX1 gene mutation

in Gene Therapy, Cell Therapy and Hematology

Hua Zhou
Jing Zhao
Xiaoyan Gu

Frontiers in Hematology

doi 10.3389/frhem.2025.1608314

337 views

Case Report

Published on 23 Jun 2025

Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa

in Blood Cancer

Lydia Lee
Emma Fosbury
Rakesh Popat
Kwee Yong
Ashutosh Wechalekar
Jeremy S. Brown
Jeffrey Huang
Sandy Mcbride
John R. Hurst

Frontiers in Hematology

doi 10.3389/frhem.2025.1502322

189 views

Mini Review

Published on 19 Jun 2025

Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients

in Blood Cancer

Joaquín Jerez
Caterina Hernandez
Charlotte N. Hill

Frontiers in Hematology

doi 10.3389/frhem.2025.1609642

545 views

Original Research

Accepted on 18 Jun 2025

Soluble immune checkpoint landscape in sickle cell disease links systemic inflammation, autoimmunity, and pain

in Red Cells, Iron and Erythropoiesis

Wei Li
Andrew Pucka
Lina Houran
Xiaoqing Huang
Candice DeBats
Brandon Reyes
Andrew RW O'Brien
Qigui Yu
Ying Wang

Frontiers in Hematology

doi 10.3389/frhem.2025.1580009

147 views

Case Report

Published on 18 Jun 2025

Successful management of acute promyelocytic leukemia in the third trimester of pregnancy: a case report and review of the literature

in Blood Cancer

Sirichai Puttirangsan
B. Prasertkanchana
Natnipa Parapob
Sirichai Srichairatanakool
Thanawat Rattanathammethee

Frontiers in Hematology

doi 10.3389/frhem.2025.1553336

632 views

Case Report

Published on 16 Jun 2025

Case Report: Expanding the ocular horizon: subperiosteal orbital hematoma and Roth spots in known case of sickle cell disease

in Red Cells, Iron and Erythropoiesis

Rajvardhan Ravindra Patil
Sourya Acharya
Vineet Karwa
Rushikesh Dhondge
Suhail Shaikh
Manjeet Kothari

Frontiers in Hematology

doi 10.3389/frhem.2025.1558509

616 views

Editorial

Published on 29 May 2025

Editorial: Investigations and management of hereditary red blood cells diseases

in Red Cells, Iron and Erythropoiesis

Imen Moumni
Foued Maaoui

Frontiers in Hematology

doi 10.3389/frhem.2025.1605163

264 views

Original Research

Published on 23 May 2025

Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients

in Blood Cancer

Lin Luo
Xiaoyan Liu
Hui Shen
Hao Zhang
Yufeng Shang
Xian Zhang
Donglei Zhang

Frontiers in Hematology

doi 10.3389/frhem.2025.1479185

571 views

Original Research

Published on 15 May 2025

Trends in hemolytic anemia-related mortality in the United States from 1999-2022

in Red Cells, Iron and Erythropoiesis

Ashley Tuin
Tabitha Diehl
Taylor Billion
Mohsin Mirza
Abubakar Tauseef
Ali Bin Abdul Jabbar

Frontiers in Hematology

doi 10.3389/frhem.2025.1560766

514 views

Original Research

Published on 14 May 2025

Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome

in Blood Cancer

Jordan Pilkington
Sophia Ly
Delice Kayishunge
Cesar Gentille
Henry K. Wong

Frontiers in Hematology

doi 10.3389/frhem.2025.1557641

708 views

Mini Review

Published on 13 May 2025

Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults

in Blood Cancer

Linda Resar
Tania Jain

Frontiers in Hematology

doi 10.3389/frhem.2024.1483322

432 views